JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.07B |
| 2 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$1.82B |
| 3 |
AT&T
T
|
+$779M |
| 4 |
Gilead Sciences
GILD
|
+$774M |
| 5 |
Eli Lilly
LLY
|
+$590M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.06B |
| 2 |
MON
Monsanto Co
MON
|
+$890M |
| 3 |
CVS Health
CVS
|
+$779M |
| 4 |
SLB Ltd
SLB
|
+$600M |
| 5 |
Chevron
CVX
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.33% |
| 2 | Healthcare | 12.01% |
| 3 | Technology | 10.9% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Industrials | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
S&T Bancorp
STBA
$1.88B
| $1.14M | ﹤0.01% |
38,536
+900
| +2% | +$25.2K |
|
|
NP
3052
DELISTED
Neenah, Inc. Common Stock
NP
| $1.13M | ﹤0.01% |
19,093
+4,341
| +29% | +$264K |
|
|
FCT
3053
First Trust Senior Floating Rate Income Fund II
FCT
$251M
| $1.13M | ﹤0.01% |
85,548
+15
| +0% | +$206 |
|
3054
HUB Group
HUBG
$2.78B
| $1.13M | ﹤0.01% |
55,840
+928
| +2% | +$19K |
|
3055
CALL
Wells Fargo
WFC
$258B
| $1.13M | ﹤0.01% |
20,000
-116,800
| -85% | -$6.51M |
|
|
CALY
3056
Callaway Golf Company
CALY
$3.33B
| $1.12M | ﹤0.01% |
125,192
+13,503
| +12% | +$129K |
|
3057
iShares MSCI Poland ETF
EPOL
$699M
| $1.12M | ﹤0.01% |
48,931
-35,488
| -42% | -$872K |
|
|
IMS
3058
DELISTED
IMS HEALTH HLDGS INC COM STK (DE)
IMS
| $1.11M | ﹤0.01% |
+36,102
| New | +$1.05M |
|
3059
WisdomTree Emerging Markets Local Debt Fund
ELD
$142M
| $1.11M | ﹤0.01% |
28,442
+916
| +3% | +$36.7K |
|
3060
iShares Short Maturity Bond ETF
NEAR
$4.83B
| $1.11M | ﹤0.01% |
+22,049
| New | +$1.11M |
|
|
XNET
3061
Xunlei
XNET
$360M
| $1.1M | ﹤0.01% |
91,801
-66,602
| -42% | -$647K |
|
|
LBY
3062
DELISTED
Libbey, Inc.
LBY
| $1.1M | ﹤0.01% |
26,728
-1,900
| -7% | -$76.8K |
|
3063
La-Z-Boy
LZB
$1.61B
| $1.1M | ﹤0.01% |
41,785
+312
| +0.8% | +$8.41K |
|
3064
AZZ Inc
AZZ
$4.36B
| $1.1M | ﹤0.01% |
21,202
-2,124
| -9% | -$103K |
|
3065
Invesco Variable Rate Preferred ETF
VRP
$2.98B
| $1.1M | ﹤0.01% |
+44,498
| New | +$1.11M |
|
3066
OSI Systems
OSIS
$3.62B
| $1.09M | ﹤0.01% |
15,440
+217
| +1% | +$15.7K |
|
3067
iShares 3-7 Year Treasury Bond ETF
IEI
$18.1B
| $1.09M | ﹤0.01% |
8,859
+694
| +8% | +$85.6K |
|
3068
PUT
Trip.com Group
TCOM
$29.3B
| $1.09M | ﹤0.01% |
30,000
+27,500
| +1,100% | +$960K |
|
3069
Global Indemnity Group
GBLI
$402M
| $1.09M | ﹤0.01% |
38,741
+1,742
| +5% | +$48.5K |
|
|
GDP
3070
DELISTED
GOODRICH PETROLEUM CORP(NEW)
GDP
| $1.08M | ﹤0.01% |
583,400
-1,815,318
| -76% | -$5.66M |
|
3071
Digi International
DGII
$2.57B
| $1.08M | ﹤0.01% |
113,318
+65,372
| +136% | +$639K |
|
3072
FlexShares STOXX Global Broad Infrastructure Index Fund
NFRA
$3.01B
| $1.08M | ﹤0.01% |
24,400
| – | – |
|
3073
Myriad Genetics
MYGN
$507M
| $1.08M | ﹤0.01% |
31,758
-5,871
| -16% | -$200K |
|
|
JPM.WS
3074
DELISTED
JPMorgan Chase
JPM.WS
| $1.08M | ﹤0.01% |
43,500
+11,500
| +36% | +$280K |
|
3075
CALL
Lumen
LUMN
$6.76B
| $1.07M | ﹤0.01% |
+36,500
| New | +$1.24M |
|
Similar funds
JP Morgan Chase's Q2 2015 Portfolio in Review
As of Q2 2015, JP Morgan Chase held 4,397 positions worth $424B, down 3.4% from $439B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2015 filing shows 356 new, 1,656 increased, 1,613 reduced and 411 closed positions. Its largest new stake was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M. The largest sale was Johnson & Johnson, an estimated $1.06B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Healthcare and Technology.
- JP Morgan Chase's largest Q2 2015 buy was Fitbit, Inc. Class A common stock: 1,923,189 shares worth $73.5M.
- JP Morgan Chase added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.07B increase.
- JP Morgan Chase's biggest Q2 2015 reduction was Johnson & Johnson, cutting an estimated $1.06B.
- JP Morgan Chase fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $342M.
- JP Morgan Chase's ten largest holdings make up 17% of its $424B portfolio in Q2 2015.
- JP Morgan Chase opened 356 new positions and closed 411 in Q2 2015.
- JP Morgan Chase's portfolio value fell 3.4% quarter-over-quarter to $424B.
Based on JP Morgan Chase's 13F filing for Q2 2015, filed 14 Aug 2015.